<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 213 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page212.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=213">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 213 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 213</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=213"><img src="../thumb/213.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>178 / 2020-04                                                        Gastro-Intestinal Tract - 12.4.4
   Pathol.hypersecret.condits.incl.Zollinger-Ellison syndr. &   Eros.reflux oesphagit: 40 mg once dly.x4 wks. If not heal./sympts.  ulc.prev.in at risk pts., duod.ulc.& prevent.of relapse of pept. ulc.as-
   idiopath.hypersecret: Init. dos. 40 mg 2xdly.then indiv.adjust.for   persist contin.for addit.4 wks.  soc.with H.pylori infect.,
   as long as need. Up to 120 mg 2xdly has been giv.  Relapse prevent.of heal.oesophagit: 20 mg once dly.  (S4) GASTRO-RESIST.TABS. 45/11.4.3/0125, 0126
   Contraindications: Substit.benzimidazol. hypersens., concom.  Symptomat.GORD: If oesophagit.not pres admin. 20 mg once dly.   720753-001: 20 mg, 30, R244,15
   atazanavir/nelfinavir.       Subseq.sympt.contr.can be achiev. on a demand regimen of 20 mg   720754-001: 40 mg, 30, R376,60
   Side effects: C.diffic.assoc.diarrh., GI disturbs. incl. candidias., resp.  once dly. If sympt. contr.not achiev.aft.4 wks.investig.furth.  Dosage:.Do not chew/crush. For pts.unable to swall.disperse in non-
   infect., sinusit., pancreatit., bld. dyscras., hypersens.reacts.incl.angi-  Contin.NSAID ther: 20-40 mg once dly.  carbon.water and drink liq.with pellets.
   oed.& anaphylax., oed., hyponatraem., hypomagnesaem., psych./   H.Pylori assoc.ulc.& relapse prevent.of such ulc: 20 mg 2xdly   Eros.reflux oesphagit: 40 mg once dly.x4 wks. Addit.4 wks.recomm.
   ren./urin.disords., CNS effs., headache, dizzin., paraesthes., fatig.,   x7 days in combinat.with amoxicillin 1 g and clarithromycin 500   if not heal./sympts persist.
   blurr.vis., vertigo, taste disturbs., bronchosp., dry mouth, stomatit.,   mg at same interv.  Relapse prevent.of heal.oesophagit: 20 mg once dly.
   incr. liv. enzym., hepatit.with/without jaund., hepat.fail., skin reacts.  (S4) GRAN, 42/11.4.3/1003  Symptomat.GORD: If oesophagit.not pres admin. 20 mg once dly.
   incl.erythem.multiforme/ Stev. -John. syndr./tox.epiderm.necrolys.,   Indications: Eros.reflux oesophagit., relapse prophylax. in heal.  Once sympt.resolv.20 mg once dly.when necess. If sympt.contr.not
   alopec., photosens., arthralg., myalg., musc.weakn., hip/ spine/ wrist   oesophagit., symptomat. treatm. of GORD, prev.gastric & duod.ulc.  achiev. aft.4 wks.investig.furth.
   fract., gynaecomast., incr.sweat., malaise.  assoc. with NSAID ther.in risk pts., duod.ulc.& prevent. of relapse of   Gastric/duod.ulc.prevent with NSAID ther: 20-40 mg once dly.
   Warnings and special precautions: Not for mild GI complaints,   such ulc.assoc.with H.pylori infect. in combinat.with appropr.anti-  H.pylori assoc.ulc.& relapse prevent.of such ulc: 20 mg in com-
   excl.poss.malign.& gastr.ulc., incr. risk of GI infects. incl.C.diffic., monit.  biot., pathologic. hypersecret. condit.incl.Zollinger-Ellison syndr.&   binat. with amoxicillin 1 g and clarithromycin 500 mg2xdly x7 days
   longt. ther., safety in pregn.& lactat.not est., no data for childr. bel.   idiopath.hypersecret.  (S4) POWD.FOR SOL.FOR INJ./INFUS. 46/11.4.3/0606
   12 yrs., sev.ren.insuff./liv.impairm., monit. concom.phenytoin init.&   715868-001: 10 mg/sachet, 28, R401,52  Indications: Alternat.to oral ther.for short.poss. durat.in eros.reflux
   when withdr., concom. anticoags., avoid concom.clopidogrel, concom.   Dosage: Disolv.sach.contents in 15 ml water and leave to thicken and   oesophagit., relapse prophylax. in heal.oesophagit., sev.reflux dis.
   high-dos.methotrex.ther., incr.wrist/hip/ spine fract. with prolong.use/  admin.within 30 mins. Admin. orally or by nasogastr.tube.  sympts., haemostas. maint.& prev.of rebleed.follow. therapeut. en-
   high dos., elderly, adeq. Vit.D & Ca intake where osteoporos.risk, sev.  Eros.reflux oesphagit: Adults & adolesc.12-18 yrs: 40 mg   doscopy for ac.bleed.gastr./duod.ulc.
   hypomagnesaem., monit.mg.lev.bef.init./ dur. ther.if prolong./with   once dly.x4 wks. If not heal./sympts. persist contin.for addit.4 wks.   723472-001: 40 mg, 10x5 ml vials, R699,20
   concom.digox./meds. caus. hypomagnesaem., concom.voriconazole   Childr.1-11 yrs: &lt;20 kg: 10 mg once dly.x8 wks. &gt;20 kg: 10-20 mg   Dosage: Discont.IV ther.& cont.with oral ther. when poss./ap-
   esp. where sev. hepat.impairm.& long.ther.indic.  once dly.x8 wks.  propr. May be admin.for up to 7 days as part of full treatm.per.for
   Interactions: Dasatinib absorpt.reduc., incr. plasma conc.of meds.me-  Relapse prevent.of heal.oesophagit: Adults & adolesc.12-18   specif.indicat.
   tabol.by CYP2C19 enzym., elimin. half-life of cisapride prolong.but not   yrs: 20 mg once dly. Childr.1-11 yrs: 10 mg once dly.  Eros.reflux.oesophagit: 40 mg once dly.x4 wks. Addit.4 wks.
   signif. incr. in peak plasma lev., elev.INH with warfar., antiplatel. eff.  Symptomat.GORD: Adults & adolesc.12-18 yrs: If oesophagit.not   recomm.when oesophgit.not heal./ sympts.persist.
   of clopidogrel poss.reduc., incr. digoxin bioavailabil., absorpt.of oral.-  pres admin. 20 mg once dly. Subseq. sympt.contr.can be achiev.on a   Relapse prophylax. in heal.oesophagit. & sev, reflux dis.
   admin.ion salts decr., methotrex.ser.conc.elev., bioavail.of any meds.  demand regimen of 20 mg once dly. If sympt.contr.not achiev. aft.4   sympts: 20 mg once dly.
   with pH depend.absorpt.potent.affect. such as prot.inhibits./antifung.  wks.investig.furth. Childr.1-11 yrs: 10 mg once dly.for upto 8 wks.  Haemostas.maint.& prev.of rebleed.of gastr./ duod.ulc: 80 mg
   agents, decr. atazanavir/ nelfinavir conc., metab.of other meds. me-  Contin.NSAID ther: Adults: 20-40 mg once dly.  as bolus infus.x30 mins.follow.by contin.IV infus.of 8 mg/hr x3 days.
   tabol. via cytochrome P450 enzym.syst.poss. affect., protease inhib.ab-  H.Pylori assoc.ulc.& relapse prevent.of such ulc: Adults:   Follow with 40 mg orally once dly.x4 wks.
   sorpt.poss.chang.by incr. gastr. pH, incr.plasma lev.with clarithromycin,   20 mg 2xdly x7 days in combinat.with amoxicillin 1 g and clarithro-  Contraindications: Substit.benzimidazol. hypersens., concom.
   decr. ser. lev.with meds.known to induce CYP2C19/ CYP23A4 or both   mycin 500 mg at same interv.  atazanavir/nelfinavir & clopidogrel
   eg.St John’s Wort/ rifampicin, both esomeprazole & voriconazole plas-  Patholog.hypersecret.condits: Adults: Init. 40 mg 2xdly.thereaft.  Side effects: C.difficile assoc.diarrh., bld. dyscras., hypersens.re-
   ma conc. poss.incr., ketoconazole & itraconazole absorpt. poss.decr.  indiv.and cont.as indicat. Dos. of upto 120 mg 2xdly.have been admin.  acts., headache, dizzin., somnol., paraesthes., insomn., confus., ag-
   NESOPRAM, (Cipla Medpro) Ranbaxy[P/S]  (S4) GRAN, 44/11.4.3/0208, 0209  gress., agitat., hallucinat., depress., blurr.vis., eye disords., vertigo,
   Esomeprazole magnes.equiv.to esomeprazole  Indications: Reduc.intra-oesophag.pH by reduc. gastric reflux   tinnit., angina, tachycard., bradycard., bronchosp., cough., periph.
   Indications: Eros.reflux oesophagit., relapse prophylax. in heal.oe-  acidity in neonates & infts, gastro-oesophag.reflux dis.confirmby   oed., hyponatraem., GI disturbs., dry mouth, stomat., candidias.,
   sophagit., symptomat.treatm. of GORD, prevent.of gastric & duod.  pH probe/ endoscopy.  pancreatit., microscop.colit., taste disturbs., incr.liv.enzym., hepatit.
   ulc.assoc.with NSAID ther., duod.ulc.& prevent.of relapse of pept.   720048-001: 2,5 mg/sachet, 28, R401,52  with/without jaund., hepat.fail., hepat.encephalopathy, skin rash.
   ulc.assoc.with H.pylori infect.  720053-001: 5 mg/sachet, 28, R401,52  incl.erythem.multiforme/Stev.-John.syndr./ tox. epiderm.necrolys.,
   (S4) GASTRO-RESIST.TABS. 45/11.4.3/0123, 0124  Dosage: Disolv.sach.contents in 5 ml water and leave to thicken   prurit., urticar., photosens., arthralg., myalg., musc. weakn., back
   721089-001: 20 mg, 30, R238,89  and admin.within 30 mins. Admin. orally or by nasogastr.tube flush.   pain, interstit. nephrit., urin. disords., impot., gynaecomast., fatig.,
   721090-001: 40 mg, 30, R367,47  nasogastric tube aft.admin. Dos.over 1,33 mg/kg/ day not stud.  hyperhidros., malaise, admin. site reacts.for parenter.admin., sev.
   Dosage: Do not chew/crush. Maybe dispers.in non-carbon.water   GORD: Childr.0-1 yrs (1-11 mnths): 3-5 kg: 2,5 mg once dly.for up   hypomagnesaem., subac.cutan.lupus erythematos(SCLE), hip/wrist/
   swallow.liq.with pellets. Admin. low.dos.& for short.treatm.durat.  to 6 wks. &gt;5-7,5 kg: 5 mg once dly.for up to 6 wks. &gt;7,5-12 kg: 10   spine fract.predom. in elderly/those with risk fact.with high dos. pro-
   for treat.condit.            mg once dly.for up to 6 wks.   long. treatm., incr.CgA lev.
   Eros.reflux oesphagit: 40 mg once dly.x4 wks. Addit.4 wks.recomm.  (S4) IV INJ/INFUS, A38/11.4.3/0384  Warnings and special precautions: Tabs.not for mild GI compl.,
   if not heal./sympts persist.  704470-002: 40 mg/vial, 10x5 ml, R810,89  excl.poss.malign., monit.long-term ther., monit.concom.warfar., incr.
   Relapse prevent.of heal.oesophagit: 20 mg once dly.  Indications: Gastroesophageal reflux dis.where oral ther.not appro-  ser.gastrin in respons.to decr.acid secret., incr.GI infects.poss. due to
   Symptomat.GORD: Without oesophagit.admin. 20 mg once dly.   pr., eros.reflux oesophagit., long-term managem.of heal.oesophagit.  incr.gastr.bact.counts, poss.Vit.B absorpt. reduct.to be consid.in pts.
   Once sympt.resolv.admin.20 mg once dly.when necess. If sympt.  to prev. relapse, short term haemostas.maint.& prevent. of rebleed.  with reduc.body stores/ risk fact.for reduc.vit.B12 absorpt., monit.Mg
   contr.not achiev. aft.4 wks.investig.furth.  follow.therapeut.endoscopy for ac. bleed. gastric/duod.ulc.  lev. bef. init./dur.prolong.ther./with concom.digox/ meds.caus.hy-
   Gastric/duod.ulc.prevent with NSAID ther: 20-40 mg once dly.  Dosage: Admin.for short.poss.time. May be giv. x7 days. Tfd.to oral   pomagnesaem., seek med.assist.& poss.discont.if SCLE les.appear
   H.Pylori assoc.ulc.& relapse prevent.of such ulc: 20 mg in com-  ther.ASAP. Reconstit.only with 0,9% NaCl for IV use. Admin.IV inj.  esp.in sun-expos. skin areas, incr.risk of SCLE if exper.aft.prev.PPI
   binat. with amoxicillin 1 g and clarithromycin 500 mg 2xdly x7 days  over 3 mins. & IV infus.over 10-30 mins.  treatm., incr.fract.risk, adeq.vit.D & Ca intake in pts. at osteoporos.
   Contra-indications: Substit.benzimidazol. hypersens., concom.  Eros.reflux oesophagit: 40 mg once dly.x4 wks.. Addit.4 wks.  risk, incr.CV events.with concom. clopidogrel theref.to be avoid., poss.
   atazanavir/nelfinavir,       recomm.where oesophagit.not heal./if sympts.persist.  interfer.with neuroendocr.tumour investig.theref. discont.5 days bef.
   Side-effects: C.diffic.assoc.diarrh., bld.dyscras., hypersens.reacts.  Long term managem.of heal.oesophagit.to prev. relapse:   CgA meas., no exper.in childr., sev. ren.insuff., max.20 mg/day in sev.
   incl.angioed.& anaphylax., headache, dizzin., paraesthes., somnol.,   20 mg once dly.  liv.impairm., consid. C.difficile diagnos.for diarrh.not improv., monit.
   psych. disords.incl.revers.confus.state, blurr.vis., vertigo, periph.  Sev.reflux dis.sympts: 20 mg once dly.  concom. phenytoin/warfar or other coumar. derivat. plasma conc.,
   oed., GI disturbs., abdom.pain, dry mouth, stomat., taste disturbs.,   Haemostas.maint.& prevent.of rebleed.of gastric /duod.ulc:   safety in pregn.& lactat.not est.
   incr.liv.enzym., hepatit. with/without jaund., hepat.encephalopathy,   80 mg as bolus infus.over 30 mins. follow.by contin.IV infus.8 mg/  Drug interactions: Absorpt.any med.whose absorpt. is pH depend.
   skin reacts.incl.erythem. multiforme/Stev.-John.syndr./ tox.epiderm.  hr over 3 days. Follow parenter.treatm.with acid suppress.ther of   potent.affect., ketoconazole & itraconazole absorpt.reduc., poss.decr.
   necrolys., photosens., arthralg., myalg., interstit.nephrit., impot., gy-  Nexiam 40 mg once dly.x4 wks.  clear.of meds. metabol.by CYP2C19 enzyme eg diazepam/ citalopram/
   naecomast., fatig., incr.sweat., malaise.  Contraindications: No paed.exper.for MUPS tabs. /inj., sachets in   imipramine/clomipramine/warfar & phenytoin, eliminat.half-life of
   Warnings and special precautions: Not for mild GI complaints,   childr.und.1 yr., safety in pregn. & lactat.not est., hypersens.to substit.   cisapride prolong., pharmacokinet./pharmacodynam.cardiovasc.event
   excl.poss.malign.& gastric ulc., monit.long-term ther., concom.clopi-  benzimidazoles, concom.atazanavir & nelfinavir  interact. with clopidogrel, atazanavir & nelfinavir conc. decr., CYP3A4
   dogrel to be avoid., safety in pregn.& lactat.not est., no exper. with   Side effects: Headache, dizzin., paraesthes., somnol., taste dis-  inhibit.clarithromyc.doubl.AUC expos., incr.methotrex./tacrolimus lev.,
   childr., sev.ren.insuffic., max.dly.dos.of 20 mg in sev.hepat.impairm.,   turbs., GI disturbs., abdom.pain, dry mouth, stomatit., GI candidias.,   digox. absorpt. incr., cilostazol AUC incr.
   incr.risk of GI infects. incl.C.diffic.,  skin reacts., alopec., photosens., bld.dyscras., rare hypersens. re-  NEXMEZOL, Sandoz [P/S]
   Drug interactions: Absorpt.of any med.whose absorpt.mechan.is   acts.incl.erythem.multiforme/Stev.-John.& tox. epiderm.necrolys.,   Esomeprazole
   influenc.by gastric acid., poss.decr.clear.of meds.metabol.by CYP2C19   periph.oed., hyponatraem., insomn., psych.disturbs., blurr.vis., verti-  Indications: Eros.reflux oesophagit., relapse prophylax. in heal.oe-
   enzyme, phenytoin & warfar.R-isomer trough plasma lev.incr., elimi-  go, bronchosp., incr.liv.enzymes, hepatit.with/without jaund., hepat.  sophagit., symptomat.treatm. of GORD, duod.ulc.& prevent.of relapse
   nat.half-life of cisapride prolong.but not signific.incr.in peak plasma   encephalopathy/fail., arthralg., myalg., gynaecomast., malaise, hy-  of pept. ulc.assoc.with H.pylori infect.
   lev., antiplatelet.eff.of clopidogrel poss.reduc., atazanavir & nelfinavir   perhidros., musc. weakn., interstit.nephrit., gastr.glandul. cysts with   (S4) TABS. 44/11.4.3/0335, 0336
   conc.decr., metabol.by CYP3A4 & concom admin.of CYP3A4 inhibit   long term.oral treatm.due to acid secret. inhibit, loc.reacts.with high   718879-001: 20 mg, 14, R119,10
   clarithromyc.doubl.esomeprazole AUC expos.  dos.IV expos.x3 days  718879-002: 20 mg, 28, R238,21
                                Special precautions: Not for mild GI complaints, excl.poss.malign.,
   NEXIAM, AstraZeneca [P/S]    monit.long-term ther., investig. GORD further if sympt.control not   718880-001: 40 mg, 14, R180,28
   Esomeprazole.                acheiv.aft.4 wks., sev.ren.insuffic., sev.imp.hepat.funct., close monit.   718880-002: 40 mg, 28, R360,66
   Indications: Eros.reflux oesophagit., relapse prophylax. in heal.  with concom.warfar./other coumar. anticoags., do not mix./co-admin.  Dosage: Swallow with liq.without crush./chew.
   oesophagit., symptomat.treatm. of GORD, prev.gastric & duod.ulc.  inj.with any other drug/ in same infus.set., incr.GI infect.(eg Salmo-  Eros.reflux oesphagit: 40 mg once dly.x4 wks. Addit.4 wks.
   assoc.with NSAID ther.in risk pts., duod.ulc.& prevent. of relapse   nella & Campylobacter.) risk due to decr. gastric. acid.incr.bact.counts  recomm.if not heal.
   of such ulc.assoc.with H.pylori infect.in combinat. with appropr.  Drug interactions: Poss.incr./decr.absorpt.of drugs whose absorpt.  Relapse prevent.of heal.oesophagit: 20 mg once dly.
   antibiot., patholog. hypersecret. condit.incl.Zollinger-Ellison syndr.&   is influenc.by gastric acid., ketoconazole & itraconazole absorpt.decr.,   Symptomat.GORD: If oesophagit.not pres admin. 20 mg once dly.
   idiopath. hypersecret.       poss. incr. plasma conc.of meds.metabol.by CYP2C19 enzyme, diaz-  Once sympt.resolv.20 mg once dly.when necess. If sympt.contr.not
   (S4) MUPS TABS. 35/11.4.3/0263, 0264  epam clear.decr., incr.phenytoin plasma conc., elev.INR with warfar.,   achiev. aft.4 wks.investig.furth.
   897132-009: 20 mg, 14, R210,40  atazanavir & nelfinavir ser.lev.decr., CYP2C19&/CYP3A4 inhibit. incr.   H.Pylori assoc.ulc.& relapse prevent.of such ulc: 20 mg in com-
   897132-017: 20 mg, 28, R420,80  esomepraz.expos., CYP2C19&/CYP3A4 induc. decr. ser.lev.  binat. with amoxicillin 1 g and clarithromycin 500 mg2xdly x7 days
   897125-002: 40 mg, 14, R324,48                             Contraindications: Substit.benzimidazol. hypersens., concom.
   897125-009: 40 mg, 28, R648,96  NEXIPRAZ, Ranbaxy [P/S]    atazanavir/nelfinavir, safety in pregn.& lactat. not est., safety & ef-
   Dosage: Swallow whole with liq., do not chew or crush. May   Esomeprazole magnes.equiv.to esomeprazole  fic.in childr.not est.
   be dispers.in non-carbon.water stir. until tabs disintergrate, drink.  Indications: Eros.reflux oesophagit., relapse prophylax. in heal.oe-  Side effects: Skin reacts.incl.erythem. multiforme/ Stev.-John.syndr./
   liq.with pellets.            sophagit., symptomat.treatm. of GORD, assoc.NSAID gastr.& duod.  tox.epiderm. necrolys., arthralg., myalg., myopathy, headache, dizzin.,</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page212.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page208.html">208</a>&nbsp;&nbsp;&nbsp;<a href="page209.html">209</a>&nbsp;&nbsp;&nbsp;<a href="page210.html">210</a>&nbsp;&nbsp;&nbsp;<a href="page211.html">211</a>&nbsp;&nbsp;&nbsp;<a href="page212.html">212</a>&nbsp;&nbsp;&nbsp;<a href="page213.html">213</a>&nbsp;&nbsp;&nbsp;<a href="page214.html">214</a>&nbsp;&nbsp;&nbsp;<a href="page215.html">215</a>&nbsp;&nbsp;&nbsp;<a href="page216.html">216</a>&nbsp;&nbsp;&nbsp;<a href="page217.html">217</a>&nbsp;&nbsp;&nbsp;<a href="page218.html">218</a>
             </td>
             <td width="35%"><a href="page214.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page214.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
